Beam Therapeutics, Inc. (BEAM)
28.34
-1.42
(-4.77%)
USD |
NASDAQ |
Aug 24, 16:00
28.46
+0.12
(+0.42%)
After-Hours: 20:00
Beam Therapeutics Shareholders Equity (Quarterly) : 1.067B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.067B |
| March 31, 2026 | 1.164B |
| December 31, 2025 | 1.238B |
| September 30, 2025 | 966.00M |
| June 30, 2025 | 1.047B |
| March 31, 2025 | 1.123B |
| December 31, 2024 | 733.54M |
| September 30, 2024 | 791.32M |
| June 30, 2024 | 854.09M |
| March 31, 2024 | 913.49M |
| December 31, 2023 | 981.33M |
| September 30, 2023 | 778.94M |
| June 30, 2023 | 811.64M |
| March 31, 2023 | 761.51M |
| December 31, 2022 | 733.47M |
| September 30, 2022 | 714.48M |
| Date | Value |
|---|---|
| June 30, 2022 | 800.16M |
| March 31, 2022 | 829.07M |
| December 31, 2021 | 826.74M |
| September 30, 2021 | 853.81M |
| June 30, 2021 | 548.55M |
| March 31, 2021 | 422.43M |
| December 31, 2020 | 245.56M |
| September 30, 2020 | 200.07M |
| June 30, 2020 | 230.82M |
| March 31, 2020 | 261.39M |
| December 31, 2019 | 100.94M |
| September 30, 2019 | 126.72M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 134.03M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Twist Bioscience Corp. | 445.74M |
| Prime Medicine, Inc. | 39.81M |
| Intellia Therapeutics, Inc. | 727.71M |
| Sana Biotechnology, Inc. | 154.57M |
| Cartesian Therapeutics, Inc. | -125.23M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.386B |
| Total Liabilities (Quarterly) | 318.91M |
| Debt to Equity Ratio | 0.2317 |
| Current Ratio | 14.57 |
| Net Debt Paydown Yield | -0.50% |